In silico and in vitro drug screening identifies new therapeutic approaches for Ewing sarcoma

The long-term overall survival of Ewing sarcoma (EWS) patients remains poor; less than 30% of patients with metastatic or recurrent disease survive despite aggressive combinations of chemotherapy, radiation and surgery. To identify new therapeutic options, we employed a multi-pronged approach using...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Pessetto, Ziyan Y., Chen, Bin, Alturkmani, Hani, Hyter, Stephen, Flynn, Colleen A., Baltezor, Michael, Ma, Yan, Rosenthal, Howard G., Neville, Kathleen A., Weir, Scott J., Butte, Atul J., Godwin, Andrew K.
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2016
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5354814/
https://ncbi.nlm.nih.gov/pubmed/27863422
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.13385
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados